glp-1 gut A sympathetic brake on release: Neuron A Specific Gut Microbiota Dysbiosis
Description
GLP1/GIP medication is used to treat type 2 diabetes, and it works by stimulating insulin release and reducing glucose production in the liver
Semaglutide, a GLP-1 receptor agonist, has been proven to help individuals lose weight by regulating appetite, reducing food cravings, and promoting better blood sugar control
On the flip side, women who had normal 28-day cycles before the medication usually bounce back to normal pretty quickly
Unfortunately, she continues to suffer from gastroparesis, which has no cure, and requires consistent medical care
Some people experience mild side effects while taking semaglutide or tirzepatide, like nausea, digestive changes, or temporary injection-site discomfort
